Cystoid macular edema in a pseudophakic patient after several glaucoma procedures. Is local therapy with bimatoprost the reason?;Zystoides makulaödem bei pseudophakie nach mehreren drucksenkenden eingriffen. Ist die lokale medikation von bimatoprost die ursache?

Klinische Monatsblatter fur Augenheilkunde

Volumn 223, Issue 6, 2006, Pages 534-537

  Kruse, Peter ^a   Rieck, P ^a   Sherif, Z ^a   Liekfeld, A ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Bimatoprost; Cataract surgery; Macular edema; Open angle glaucoma; Prostaglandin like drugs; Pseudophakia; Uveoscleral drain

Indexed keywords

BIMATOPROST;

AGED; ARTICLE; BLURRED VISION; CASE REPORT; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; LENS IMPLANT; PSEUDOPHAKIA; RETINA MACULA CYSTOID EDEMA;

ADMINISTRATION, TOPICAL; AGED; AMIDES; GLAUCOMA; HUMANS; LIPIDS; MACULAR EDEMA, CYSTOID; MALE; PSEUDOPHAKIA;

EID: 33746916483     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-858992     Document Type: Article

References (11)

1. Sharif NA, Williams GW, Kelly CR et al. Bimatoprost and its free acid are prostaglandin FP receptor agonists. Eur J Pharmacol (Netherlands) 2001; 432 (2-3): 211-213
2. Eisenberg DL, Toris CB, Camras CB. Bimatoprost and travoprost: a review of recent studies of two new glaucoma drugs. Surv Ophthalmol (United States) 2002; 47 Suppl 1: 105-115
3. Wand M, Gaudio AR. Cystoid macular edema associated with ocular hypotensive lipids. Am J Ophthalmol (United States) 2002; 133 (3): 403-405
4. Ayyala RS, Cruz DA, Margo CE et al. Cystoid macular edema associated with latanoprost in aphakic and pseudophakic eyes. Am J Ophthalmol (United States) 1998; 126 (4): 602-604
5. Moroi SE, Gottfredsdottir MS, Schteingart MT et al. Cystoid macular edema associated with latanoprost therapy in a case series of patients with glaucoma and ocular hypertension. Ophthalmology (United States) 1999; 106 (5): 1024-1029
6. Wand M, Gaudio AR. Cystoid macular edema associated with ocular hypotensive lipids. Am J Ophthalmol 2002; 133 (3): 403-405
7. Gaton DD, Sagara T, Lindsey JD et al. Increased matrix metalloproteinases 1, 2, and 3 in the monkey uveoscleral outflow pathway after topical prostaglandin F(2 alpha)-isopropyl ester treatment. Arch Ophthalmol (United States) 2001; 119 (8): 1165-1170
8. Eisenberg D. Latanoprost and cystoid macular edema. J Cataract Refract Surg (United States) 2003; 29 (6): 1053-1054
9. Thureson-Klein A, Hedqvist P, Lindbom L et al. Leukocyte diapedesis and plasma extravasation after leukotriene B4: lack of structural injury to the endothelium. Tissue Cell (England) 1986; 18 (1): 1-12
10. Woodward DF, Krauss AH, Chen J et al. Pharmacological characterization of a novel antiglaucoma agent. Bimatoprost (AGN 192024) J Pharmacol Exp Ther (United States) 2003; 305 (2): 772-785
11. Zeitz O, Matthiessen ET, Wiermann A et al. Ocular hemodynamics in normal tension glaucoma: effect of bimatoprost. Klin Monatsbl Augenheilkd (Germany) 2004; 221 (7): 550-554